Skip to main content
European Commission logo print header

Diagnosing platform for neurological and mental disorders based on the analysis of ocular and oculocephalic movements.

Cel

The first product that AURA will launch to the market will be OSCANN, a diagnosis platform that will allow better, faster
and more accurate diagnosis of neurological disorders affecting Europe’s population in general, but specially youngsters
(e.g. ADHD) and elders (e.g. Parkinson). OSCANN allows for the measurement and analysis of ocular and oculocephalic
movements (OM/OCM) and combines the result with data obtained from other sources (clinical histories, medical
explorations, complementary tests and biomarkers) using Artificial Intelligence (AI) techniques to improve significantly the
quality of medical diagnosis in early stages.

Zaproszenie do składania wniosków

H2020-SMEInst-2016-2017

Zobacz inne projekty w ramach tego zaproszenia

Szczegółowe działanie

H2020-SMEINST-1-2016-2017

Koordynator

AURA INNOVATIVE ROBOTICS, SL
Wkład UE netto
€ 50 000,00
Adres
CALLE YARUMAL 2 1 A
28045 MADRID
Hiszpania

Zobacz na mapie

MŚP

Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant.

Tak
Region
Comunidad de Madrid Comunidad de Madrid Madrid
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Linki
Koszt całkowity
€ 71 429,00